Testimonials

  1. Thanks to DRSplus, we doubled the number of patients that are in our diabetic retinopathy screening.

    Dr. Alberto Piatti, ASLTO5 Oculistica Distrettuale, Moncalieri, Italy

  2. Thanks to the high resolution of its confocal true color images, UWF imaging with the EIDON has been particularly helpful to me for detecting and evaluating hemorrhages and microvascular lesions in patients with diabetic retinopathy.

    Prof. Giuseppe Querques, University Vita Salute, Milan, Italy

  3. Images from fundus photography have a critical role in guiding treatment decisions and the confocal true color images from the EIDON platform provide a natural perception of the retina’s appearance that represents vital information in my daily practice.

    Prof. Giuseppe Querques, University Vita Salute, Milan, Italy

  4. Rebound tonometry is a great alternative to the Goldmann applanation tonometer in both screening and follow-up of glaucoma patients. It is a very reliable technology with a wide range of clinical applications and its use has become widespread in our practices.

    Prof. Jose M Martinez de la Casa, Hospital Clinico Madrid. Clinica Martinez de la Casa Matilla, Madrid, Spain

  5. With the benefit of true color imaging, I am confident in my ability to discriminate between normal tissue and potential signs of pathology. (EIDON, DRSplus)

    Prof. Giuseppe Querques, University Vita Salute, Milan, Italy

  6. DRSplus is an efficient and easy-to-use device, that can be used with a wide range of patients. It is an extremely versatile device. It can be used from different type of operators: ophthalmologists,
    diabetologists, nurses or optometrists.

    Dr. Alberto Piatti, ASLTO5 Oculistica Distrettuale, Moncalieri, Italy

  7. As early adopters of Icare technology, we have many years of experience with the devices. The ic100 has been a wonderful advancement.  The added features that assist the operator with proper alignment ensures the measurements are repeatable and accurate. It is a true timesaver that provides us with measurements we can trust.

    Ron Melton, OD Charlotte Eye Ear Nose & Throat Associates, P.A. Charlotte, NC Randall K. Thomas, OD Cabarrus Eye Center, Concord, NC

  8. In patients with glaucoma, there is a possibility of their eye pressure either fluctuating significantly or being outside the target range (as determined by their doctor). Both these changes are associated with worsening of glaucoma. Monitoring for these changes between office visits can help reassure the doctor and the patient that the therapy is adequate and that the patient is compliant with treatment. If the eye pressure is not stable, then the doctor can recommend additional treatment or tailor the eye drop regimen to stabilize the pressure before permanent loss of tissue or visual field occurs.

    SANJAY ASRANI, MD, PROFESSOR OF OPHTHALMOLOGY DUKE EYE CENTER, DURHAM, NC, USA

  9. In patients with suspected glaucoma, daily intraocular pressure monitoring is also essential. In a high proportion of these patients, IOP elevations may be missed during regular scheduled examinations. Knowing these pres- sure peaks exist can help control the disease and person- alize and optimize the treatment regimen. Autotonometry is an efficient option for this purpose, as well as being comfortable for the patient.

    JOSÉ MARÍA MARTÍNEZ DE LA CASA, MD, PROFESSOR OF OPHTHALMOLOGY UNIVERSITY OF MADRID, SPAIN

  10. Taking normal iCare measurements is very straight-forward – I can train novice technicians in 15 minutes. Teaching patients to take their own measurements takes a little longer but is time well spent (around 20 minutes to set-up the device to fit their face and train). The effort is worthwhile because when the patient returns you have a set of IOP measurements for both eyes taken at different times day.

    ROBERT HARVEY, CONSULTANT OPHTHALMOLOGIST, VICTORIA, AUSTRALIA